刊物主题:Medicine & Public Health Oncology Gastroenterology Surgical Oncology Pathology Radiotherapy
出版者:Springer Japan
ISSN:1436-3305
文摘
Background Recent studies have discovered recurrent RHOA mutations in diffuse-type gastric cancers. These reports show mutant RhoA is an important cancer driver and is a potential therapeutic target. This study aims to investigate the clinicopathological features of diffuse-type gastric cancers with RHOA mutation.